25 XP   0   0   10

Bio-Rad Laboratories Inc
Buy, Hold or Sell?

Let's analyse Bio-rad together

PenkeI guess you are interested in Bio-Rad Laboratories Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bio-Rad Laboratories Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bio-Rad Laboratories Inc

I send you an email if I find something interesting about Bio-Rad Laboratories Inc.

Quick analysis of Bio-rad (30 sec.)










What can you expect buying and holding a share of Bio-rad? (30 sec.)

How much money do you get?

How much money do you get?
$13,708.24
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
$299.26
Expected worth in 1 year
$205.02
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
$13,614.00
Return On Investment
4,863.7%

For what price can you sell your share?

Current Price per Share
$279.91
Expected price per share
$271.00 - $300.10
How sure are you?
50%

1. Valuation of Bio-rad (5 min.)




Live pricePrice per Share (EOD)

$279.91

Intrinsic Value Per Share

$-50.97 - $118.79

Total Value Per Share

$248.29 - $418.05

2. Growth of Bio-rad (5 min.)




Is Bio-rad growing?

Current yearPrevious yearGrowGrow %
How rich?$8.7b$9.6b-$874.1m-10.0%

How much money is Bio-rad making?

Current yearPrevious yearGrowGrow %
Making money-$637.3m-$3.6b$2.9b469.2%
Net Profit Margin-23.9%-129.5%--

How much money comes from the company's main activities?

3. Financial Health of Bio-rad (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#9 / 332

Most Revenue
#31 / 332

Most Profit
#327 / 332

Most Efficient
#178 / 332

What can you expect buying and holding a share of Bio-rad? (5 min.)

Welcome investor! Bio-rad's management wants to use your money to grow the business. In return you get a share of Bio-rad.

What can you expect buying and holding a share of Bio-rad?

First you should know what it really means to hold a share of Bio-rad. And how you can make/lose money.

Speculation

The Price per Share of Bio-rad is $279.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bio-rad.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bio-rad, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $299.26. Based on the TTM, the Book Value Change Per Share is $-23.56 per quarter. Based on the YOY, the Book Value Change Per Share is $-129.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $3,427.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bio-rad.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-21.82-7.8%-21.82-7.8%-121.79-43.5%36.2813.0%20.547.3%
Usd Book Value Change Per Share-23.56-8.4%-23.56-8.4%-129.61-46.3%33.2811.9%22.368.0%
Usd Dividend Per Share3,427.061,224.3%3,427.061,224.3%2,289.21817.8%1,402.37501.0%701.20250.5%
Usd Total Gains Per Share3,403.501,215.9%3,403.501,215.9%2,159.59771.5%1,435.65512.9%723.56258.5%
Usd Price Per Share320.65-320.65-404.66-478.39-304.34-
Price to Earnings Ratio-14.70--14.70--3.32--0.40-28.44-
Price-to-Total Gains Ratio0.09-0.09-0.19-1.40-13.45-
Price to Book Ratio1.07-1.07-1.25-1.52-1.39-
Price-to-Total Gains Ratio0.09-0.09-0.19-1.40-13.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share279.91
Number of shares3
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share3,427.061,402.37
Usd Book Value Change Per Share-23.5633.28
Usd Total Gains Per Share3,403.501,435.65
Gains per Quarter (3 shares)10,210.504,306.94
Gains per Year (3 shares)40,842.0017,227.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
141125-283408321682839917218
282249-565816743365779934446
3123374-84812251650485119851674
4164499-113116335867314159868902
5205624-141420420084142199786130
6246748-16962450421009702396103358
7287873-19792858841177992796120586
8328998-22623267261346273195137814
9370122-25453675681514553595155042
10411247-28274084101682843994172270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%33.02.00.094.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%32.03.00.091.4%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.04.060.0%7.00.028.020.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%34.01.00.097.1%

Fundamentals of Bio-rad

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Fundamental data was last updated by Penke on 2024-04-30 19:52:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Bio-Rad Laboratories Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bio-rad earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bio-rad to the Medical Devices industry mean.
  • A Net Profit Margin of -23.9% means that $-0.24 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bio-Rad Laboratories Inc:

  • The MRQ is -23.9%. The company is making a huge loss. -2
  • The TTM is -23.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-23.9%TTM-23.9%0.0%
TTM-23.9%YOY-129.5%+105.6%
TTM-23.9%5Y43.6%-67.5%
5Y43.6%10Y25.0%+18.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.9%-15.1%-8.8%
TTM-23.9%-20.4%-3.5%
YOY-129.5%-13.3%-116.2%
5Y43.6%-20.4%+64.0%
10Y25.0%-27.3%+52.3%
1.1.2. Return on Assets

Shows how efficient Bio-rad is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bio-rad to the Medical Devices industry mean.
  • -5.2% Return on Assets means that Bio-rad generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bio-Rad Laboratories Inc:

  • The MRQ is -5.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.2%TTM-5.2%0.0%
TTM-5.2%YOY-26.9%+21.7%
TTM-5.2%5Y8.6%-13.8%
5Y8.6%10Y5.9%+2.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.2%-4.0%-1.2%
TTM-5.2%-4.5%-0.7%
YOY-26.9%-4.3%-22.6%
5Y8.6%-3.8%+12.4%
10Y5.9%-4.8%+10.7%
1.1.3. Return on Equity

Shows how efficient Bio-rad is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bio-rad to the Medical Devices industry mean.
  • -7.3% Return on Equity means Bio-rad generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bio-Rad Laboratories Inc:

  • The MRQ is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-7.3%0.0%
TTM-7.3%YOY-37.7%+30.4%
TTM-7.3%5Y11.1%-18.3%
5Y11.1%10Y7.8%+3.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-4.2%-3.1%
TTM-7.3%-5.6%-1.7%
YOY-37.7%-5.3%-32.4%
5Y11.1%-6.1%+17.2%
10Y7.8%-6.7%+14.5%

1.2. Operating Efficiency of Bio-Rad Laboratories Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bio-rad is operating .

  • Measures how much profit Bio-rad makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bio-rad to the Medical Devices industry mean.
  • An Operating Margin of 14.4% means the company generated $0.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bio-Rad Laboratories Inc:

  • The MRQ is 14.4%. The company is operating less efficient.
  • The TTM is 14.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ14.4%TTM14.4%0.0%
TTM14.4%YOY17.2%-2.9%
TTM14.4%5Y14.9%-0.5%
5Y14.9%10Y11.3%+3.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.4%-24.6%+39.0%
TTM14.4%-16.7%+31.1%
YOY17.2%-12.3%+29.5%
5Y14.9%-19.9%+34.8%
10Y11.3%-25.7%+37.0%
1.2.2. Operating Ratio

Measures how efficient Bio-rad is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are $0.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bio-Rad Laboratories Inc:

  • The MRQ is 0.856. The company is less efficient in keeping operating costs low.
  • The TTM is 0.856. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.856TTM0.8560.000
TTM0.856YOY0.828+0.029
TTM0.8565Y0.851+0.005
5Y0.85110Y0.891-0.039
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8561.430-0.574
TTM0.8561.426-0.570
YOY0.8281.390-0.562
5Y0.8511.416-0.565
10Y0.8911.375-0.484

1.3. Liquidity of Bio-Rad Laboratories Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bio-rad is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 5.83 means the company has $5.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bio-Rad Laboratories Inc:

  • The MRQ is 5.831. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.831. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.831TTM5.8310.000
TTM5.831YOY5.553+0.278
TTM5.8315Y4.020+1.811
5Y4.02010Y4.032-0.012
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8312.688+3.143
TTM5.8312.724+3.107
YOY5.5533.429+2.124
5Y4.0203.619+0.401
10Y4.0323.507+0.525
1.3.2. Quick Ratio

Measures if Bio-rad is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bio-rad to the Medical Devices industry mean.
  • A Quick Ratio of 6.36 means the company can pay off $6.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bio-Rad Laboratories Inc:

  • The MRQ is 6.356. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.356. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.356TTM6.3560.000
TTM6.356YOY6.423-0.068
TTM6.3565Y4.046+2.309
5Y4.04610Y3.700+0.346
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.3561.521+4.835
TTM6.3561.671+4.685
YOY6.4232.113+4.310
5Y4.0462.316+1.730
10Y3.7002.425+1.275

1.4. Solvency of Bio-Rad Laboratories Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bio-rad assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bio-rad to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.29 means that Bio-rad assets are financed with 28.9% credit (debt) and the remaining percentage (100% - 28.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bio-Rad Laboratories Inc:

  • The MRQ is 0.289. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.289. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.289TTM0.2890.000
TTM0.289YOY0.288+0.001
TTM0.2895Y0.266+0.024
5Y0.26610Y0.293-0.027
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2890.399-0.110
TTM0.2890.390-0.101
YOY0.2880.348-0.060
5Y0.2660.442-0.176
10Y0.2930.458-0.165
1.4.2. Debt to Equity Ratio

Measures if Bio-rad is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bio-rad to the Medical Devices industry mean.
  • A Debt to Equity ratio of 40.7% means that company has $0.41 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bio-Rad Laboratories Inc:

  • The MRQ is 0.407. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.407. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.407TTM0.4070.000
TTM0.407YOY0.404+0.003
TTM0.4075Y0.363+0.044
5Y0.36310Y0.418-0.054
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4070.576-0.169
TTM0.4070.562-0.155
YOY0.4040.497-0.093
5Y0.3630.626-0.263
10Y0.4180.696-0.278

2. Market Valuation of Bio-Rad Laboratories Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bio-rad generates.

  • Above 15 is considered overpriced but always compare Bio-rad to the Medical Devices industry mean.
  • A PE ratio of -14.70 means the investor is paying $-14.70 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bio-Rad Laboratories Inc:

  • The EOD is -12.828. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.696. Based on the earnings, the company is expensive. -2
  • The TTM is -14.696. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.828MRQ-14.696+1.867
MRQ-14.696TTM-14.6960.000
TTM-14.696YOY-3.323-11.373
TTM-14.6965Y-0.396-14.299
5Y-0.39610Y28.440-28.836
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-12.828-1.085-11.743
MRQ-14.696-1.794-12.902
TTM-14.696-2.279-12.417
YOY-3.323-2.674-0.649
5Y-0.396-2.530+2.134
10Y28.440-2.057+30.497
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bio-Rad Laboratories Inc:

  • The EOD is 37.459. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 42.911. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 42.911. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD37.459MRQ42.911-5.452
MRQ42.911TTM42.9110.000
TTM42.911YOY150.116-107.205
TTM42.9115Y60.236-17.325
5Y60.23610Y-21.813+82.050
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD37.459-1.067+38.526
MRQ42.911-1.662+44.573
TTM42.911-3.006+45.917
YOY150.116-6.187+156.303
5Y60.236-4.921+65.157
10Y-21.813-5.292-16.521
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bio-rad is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.07 means the investor is paying $1.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bio-Rad Laboratories Inc:

  • The EOD is 0.935. Based on the equity, the company is cheap. +2
  • The MRQ is 1.071. Based on the equity, the company is underpriced. +1
  • The TTM is 1.071. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.935MRQ1.071-0.136
MRQ1.071TTM1.0710.000
TTM1.071YOY1.254-0.182
TTM1.0715Y1.523-0.451
5Y1.52310Y1.389+0.134
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.9351.999-1.064
MRQ1.0712.384-1.313
TTM1.0712.530-1.459
YOY1.2543.169-1.915
5Y1.5233.955-2.432
10Y1.3894.369-2.980
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bio-Rad Laboratories Inc.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bio-Rad Laboratories Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---23.560-23.5600%-129.612+450%33.283-171%22.361-205%
Book Value Per Share--299.262299.2620%322.822-7%318.554-6%207.013+45%
Current Ratio--5.8315.8310%5.553+5%4.020+45%4.032+45%
Debt To Asset Ratio--0.2890.2890%0.288+0%0.266+9%0.293-1%
Debt To Equity Ratio--0.4070.4070%0.404+1%0.363+12%0.418-3%
Dividend Per Share--3427.0603427.0600%2289.206+50%1402.365+144%701.197+389%
Eps---21.819-21.8190%-121.791+458%36.283-160%20.535-206%
Free Cash Flow Per Share--7.4727.4720%2.696+177%11.121-33%7.008+7%
Free Cash Flow To Equity Per Share---7.100-7.1000%35.382-120%10.757-166%6.766-205%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.000+0%
Intrinsic Value_10Y_max--118.786--------
Intrinsic Value_10Y_min---50.975--------
Intrinsic Value_1Y_max--11.315--------
Intrinsic Value_1Y_min--3.994--------
Intrinsic Value_3Y_max--34.445--------
Intrinsic Value_3Y_min--4.187--------
Intrinsic Value_5Y_max--58.116--------
Intrinsic Value_5Y_min---4.182--------
Market Cap1426401766.300-557%9365865850.0009365865850.0000%12052798100.000-22%14345739926.000-35%9126640503.000+3%
Net Profit Margin---0.239-0.2390%-1.295+443%0.436-155%0.250-195%
Operating Margin--0.1440.1440%0.172-17%0.149-3%0.113+27%
Operating Ratio--0.8560.8560%0.828+3%0.851+1%0.891-4%
Pb Ratio0.935-15%1.0711.0710%1.254-15%1.523-30%1.389-23%
Pe Ratio-12.828+13%-14.696-14.6960%-3.323-77%-0.396-97%28.440-152%
Price Per Share279.910-15%320.650320.6500%404.660-21%478.394-33%304.337+5%
Price To Free Cash Flow Ratio37.459-15%42.91142.9110%150.116-71%60.236-29%-21.813+151%
Price To Total Gains Ratio0.082-15%0.0940.0940%0.187-50%1.403-93%13.448-99%
Quick Ratio--6.3566.3560%6.423-1%4.046+57%3.700+72%
Return On Assets---0.052-0.0520%-0.269+418%0.086-160%0.059-188%
Return On Equity---0.073-0.0730%-0.377+417%0.111-166%0.078-194%
Total Gains Per Share--3403.5003403.5000%2159.594+58%1435.648+137%723.558+370%
Usd Book Value--8741133000.0008741133000.0000%9615252000.000-9%9531703200.000-8%6186699700.000+41%
Usd Book Value Change Per Share---23.560-23.5600%-129.612+450%33.283-171%22.361-205%
Usd Book Value Per Share--299.262299.2620%322.822-7%318.554-6%207.013+45%
Usd Dividend Per Share--3427.0603427.0600%2289.206+50%1402.365+144%701.197+389%
Usd Eps---21.819-21.8190%-121.791+458%36.283-160%20.535-206%
Usd Free Cash Flow--218263000.000218263000.0000%80290000.000+172%334008800.000-35%209900200.000+4%
Usd Free Cash Flow Per Share--7.4727.4720%2.696+177%11.121-33%7.008+7%
Usd Free Cash Flow To Equity Per Share---7.100-7.1000%35.382-120%10.757-166%6.766-205%
Usd Market Cap1426401766.300-557%9365865850.0009365865850.0000%12052798100.000-22%14345739926.000-35%9126640503.000+3%
Usd Price Per Share279.910-15%320.650320.6500%404.660-21%478.394-33%304.337+5%
Usd Profit---637324000.000-637324000.0000%-3627535000.000+469%1112460400.000-157%626810100.000-202%
Usd Revenue--2671262000.0002671262000.0000%2802249000.000-5%2650668200.000+1%2396626000.000+11%
Usd Total Gains Per Share--3403.5003403.5000%2159.594+58%1435.648+137%723.558+370%
 EOD+3 -5MRQTTM+0 -0YOY+20 -155Y+11 -2410Y+23 -13

4.2. Fundamental Score

Let's check the fundamental score of Bio-Rad Laboratories Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.828
Price to Book Ratio (EOD)Between0-10.935
Net Profit Margin (MRQ)Greater than0-0.239
Operating Margin (MRQ)Greater than00.144
Quick Ratio (MRQ)Greater than16.356
Current Ratio (MRQ)Greater than15.831
Debt to Asset Ratio (MRQ)Less than10.289
Debt to Equity Ratio (MRQ)Less than10.407
Return on Equity (MRQ)Greater than0.15-0.073
Return on Assets (MRQ)Greater than0.05-0.052
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Bio-Rad Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.841
Ma 20Greater thanMa 50327.689
Ma 50Greater thanMa 100320.047
Ma 100Greater thanMa 200316.467
OpenGreater thanClose279.910
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Liabilities  158,49066,454224,944-14,274210,670-24,469186,201-35,606,592-35,420,391
Other Stockholders Equity  371,623-42,154329,4695,974335,443-151,575183,868-367,329-183,461



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets12,299,070
Total Liabilities3,557,937
Total Stockholder Equity8,741,133
 As reported
Total Liabilities 3,557,937
Total Stockholder Equity+ 8,741,133
Total Assets = 12,299,070

Assets

Total Assets12,299,070
Total Current Assets3,048,330
Long-term Assets9,250,740
Total Current Assets
Cash And Cash Equivalents 403,966
Short-term Investments 1,208,887
Net Receivables 500,917
Inventory 780,517
Other Current Assets 154,043
Total Current Assets  (as reported)3,048,330
Total Current Assets  (calculated)3,048,330
+/-0
Long-term Assets
Property Plant Equipment 723,737
Goodwill 413,600
Long Term Investments 7,698,070
Intangible Assets 320,500
Long-term Assets  (as reported)9,250,740
Long-term Assets  (calculated)9,155,907
+/- 94,833

Liabilities & Shareholders' Equity

Total Current Liabilities522,799
Long-term Liabilities3,035,138
Total Stockholder Equity8,741,133
Total Current Liabilities
Short-term Debt 41,365
Short Long Term Debt 486
Accounts payable 142,825
Other Current Liabilities -35,420,391
Total Current Liabilities  (as reported)522,799
Total Current Liabilities  (calculated)-35,235,715
+/- 35,758,514
Long-term Liabilities
Long term Debt 1,199,052
Capital Lease Obligations 205,857
Long-term Liabilities Other 195,113
Long-term Liabilities  (as reported)3,035,138
Long-term Liabilities  (calculated)1,600,022
+/- 1,435,116
Total Stockholder Equity
Common Stock3
Retained Earnings 9,260,629
Accumulated Other Comprehensive Income -336,038
Other Stockholders Equity -183,461
Total Stockholder Equity (as reported)8,741,133
Total Stockholder Equity (calculated)8,741,133
+/-0
Other
Capital Stock3
Cash and Short Term Investments 1,612,853
Common Stock Shares Outstanding 29,209
Current Deferred Revenue35,759,000
Liabilities and Stockholders Equity 12,299,070
Net Debt 1,001,929
Net Invested Capital 9,940,671
Net Working Capital 2,525,531
Property Plant and Equipment Gross 1,790,430
Short Long Term Debt Total 1,405,895



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-311989-12-311988-12-311987-12-311986-12-311985-12-31
> Total Assets 
71,500
101,600
132,000
155,300
184,400
213,200
253,100
272,700
259,900
263,700
285,100
284,900
351,900
367,300
668,900
646,278
684,028
720,703
986,858
1,392,002
1,426,582
1,596,168
1,971,594
2,037,264
2,535,853
3,062,764
3,096,803
3,431,616
3,388,790
3,341,278
3,711,542
3,850,504
4,272,021
5,603,565
8,008,859
12,972,618
17,775,795
13,501,666
12,299,070
12,299,07013,501,66617,775,79512,972,6188,008,8595,603,5654,272,0213,850,5043,711,5423,341,2783,388,7903,431,6163,096,8033,062,7642,535,8532,037,2641,971,5941,596,1681,426,5821,392,002986,858720,703684,028646,278668,900367,300351,900284,900285,100263,700259,900272,700253,100213,200184,400155,300132,000101,60071,500
   > Total Current Assets 
53,900
63,100
85,400
101,700
124,000
147,200
166,800
181,300
169,600
178,300
201,600
198,500
227,400
235,400
378,700
369,668
430,828
465,796
670,878
911,224
1,008,211
1,129,777
1,028,974
1,093,941
1,562,674
1,975,346
1,798,155
1,924,794
1,747,856
1,716,367
1,777,596
1,844,524
1,977,135
2,024,353
2,180,155
2,139,835
1,989,088
3,157,976
3,048,330
3,048,3303,157,9761,989,0882,139,8352,180,1552,024,3531,977,1351,844,5241,777,5961,716,3671,747,8561,924,7941,798,1551,975,3461,562,6741,093,9411,028,9741,129,7771,008,211911,224670,878465,796430,828369,668378,700235,400227,400198,500201,600178,300169,600181,300166,800147,200124,000101,70085,40063,10053,900
       Cash And Cash Equivalents 
6,000
2,100
1,900
4,000
2,900
2,000
4,800
2,700
3,100
3,800
14,800
9,400
10,800
10,100
17,100
13,954
47,129
27,733
148,642
195,734
296,716
223,607
161,764
204,524
649,938
906,551
574,231
463,388
331,551
413,251
457,549
456,264
383,824
431,526
660,672
662,205
470,783
434,215
403,966
403,966434,215470,783662,205660,672431,526383,824456,264457,549413,251331,551463,388574,231906,551649,938204,524161,764223,607296,716195,734148,64227,73347,12913,95417,10010,10010,8009,40014,8003,8003,1002,7004,8002,0002,9004,0001,9002,1006,000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
165,899
116,343
264,473
61,977
38,950
94,876
118,636
238,884
457,685
277,369
284,384
332,928
387,736
376,714
418,830
459,533
334,473
404,695
1,362,017
1,208,887
1,208,8871,362,017404,695334,473459,533418,830376,714387,736332,928284,384277,369457,685238,884118,63694,87638,95061,977264,473116,343165,8990000000000000000000
       Net Receivables 
23,100
28,600
39,400
46,700
59,200
70,500
76,200
76,200
75,800
81,700
92,100
97,800
97,000
106,000
193,900
182,242
194,400
212,282
234,085
261,243
247,192
292,970
358,076
339,653
345,734
387,996
398,674
398,739
422,660
377,640
391,485
372,348
464,847
393,146
392,672
419,424
423,537
494,645
500,917
500,917494,645423,537419,424392,672393,146464,847372,348391,485377,640422,660398,739398,674387,996345,734339,653358,076292,970247,192261,243234,085212,282194,400182,242193,900106,00097,00097,80092,10081,70075,80076,20076,20070,50059,20046,70039,40028,60023,100
       Inventory 
21,300
26,000
37,400
44,200
53,200
63,200
72,100
82,400
72,100
73,300
75,400
69,700
91,400
92,400
126,300
132,519
139,179
166,372
190,258
205,512
212,342
253,045
321,015
375,616
351,206
398,100
433,510
448,370
501,291
470,997
490,224
524,961
594,804
584,334
554,007
622,253
572,239
719,316
780,517
780,517719,316572,239622,253554,007584,334594,804524,961490,224470,997501,291448,370433,510398,100351,206375,616321,015253,045212,342205,512190,258166,372139,179132,519126,30092,40091,40069,70075,40073,30072,10082,40072,10063,20053,20044,20037,40026,00021,300
       Other Current Assets 
3,500
6,400
6,700
6,800
8,700
11,500
13,700
20,000
18,600
19,500
19,300
21,600
28,200
26,900
41,400
40,953
50,120
59,409
97,893
82,836
135,618
95,682
126,142
135,198
120,920
157,641
152,856
156,612
214,985
170,095
105,410
103,215
156,946
196,517
113,271
101,480
117,834
147,783
154,043
154,043147,783117,834101,480113,271196,517156,946103,215105,410170,095214,985156,612152,856157,641120,920135,198126,14295,682135,61882,83697,89359,40950,12040,95341,40026,90028,20021,60019,30019,50018,60020,00013,70011,5008,7006,8006,7006,4003,500
   > Long-term Assets 
17,600
38,500
46,600
53,600
60,400
66,000
86,300
91,400
90,300
85,400
83,500
86,400
124,500
131,900
290,200
276,610
253,200
254,907
315,980
480,778
418,371
466,391
942,620
943,323
973,179
1,087,418
1,298,648
1,506,822
1,640,934
1,624,911
1,933,946
2,005,980
2,294,886
3,579,212
5,828,704
10,832,783
15,786,707
10,343,690
9,250,740
9,250,74010,343,69015,786,70710,832,7835,828,7043,579,2122,294,8862,005,9801,933,9461,624,9111,640,9341,506,8221,298,6481,087,418973,179943,323942,620466,391418,371480,778315,980254,907253,200276,610290,200131,900124,50086,40083,50085,40090,30091,40086,30066,00060,40053,60046,60038,50017,600
       Property Plant Equipment 
13,800
33,900
40,400
44,000
50,100
56,400
76,500
82,500
80,900
75,600
73,000
71,900
78,700
82,100
125,900
119,032
132,974
142,235
179,123
202,324
180,258
189,627
271,561
300,732
302,417
333,617
349,501
416,938
429,355
428,836
437,690
488,614
493,496
508,690
701,207
693,507
695,750
679,564
723,737
723,737679,564695,750693,507701,207508,690493,496488,614437,690428,836429,355416,938349,501333,617302,417300,732271,561189,627180,258202,324179,123142,235132,974119,032125,90082,10078,70071,90073,00075,60080,90082,50076,50056,40050,10044,00040,40033,90013,800
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119,492
328,439
321,820
327,626
363,981
468,933
495,418
517,770
500,441
495,948
477,115
506,069
219,770
264,131
291,916
347,343
406,488
413,600
413,600406,488347,343291,916264,131219,770506,069477,115495,948500,441517,770495,418468,933363,981327,626321,820328,439119,492000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
377,870
389,309
719,840
830,790
1,027,736
2,655,709
4,638,205
9,561,140
14,387,006
8,830,892
7,698,070
7,698,0708,830,89214,387,0069,561,1404,638,2052,655,7091,027,736830,790719,840389,309377,8700000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
27,700
18,600
105,400
90,970
75,873
69,519
69,503
171,914
141,725
44,605
210,304
228,590
204,779
203,881
259,497
260,939
266,188
254,228
214,026
161,609
174,113
125,123
145,525
199,497
253,939
332,147
320,500
320,500332,147253,939199,497145,525125,123174,113161,609214,026254,228266,188260,939259,497203,881204,779228,590210,30444,605141,725171,91469,50369,51975,87390,970105,40018,60027,700000000000000
       Long-term Assets Other 
3,800
4,600
6,200
9,600
10,300
9,600
9,800
8,900
9,400
9,800
10,500
14,500
18,100
31,200
58,900
66,608
44,353
43,153
67,354
79,996
82,385
103,567
111,887
92,181
138,357
185,939
220,717
24,050
-162,060,249
-154,864,903
-233,408,558
-222,871,148
-222,115,528
-553,169,080
-997,707,364
-2,076,698,277
-3,058,977,331
-1,770,386,401
-1,475,400,570
-1,475,400,570-1,770,386,401-3,058,977,331-2,076,698,277-997,707,364-553,169,080-222,115,528-222,871,148-233,408,558-154,864,903-162,060,24924,050220,717185,939138,35792,181111,887103,56782,38579,99667,35443,15344,35366,60858,90031,20018,10014,50010,5009,8009,4008,9009,8009,60010,3009,6006,2004,6003,800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,477
0
0
0
0
0
0
0
0
0
0
0
0000000000015,477000000000000000000000000000
> Total Liabilities 
41,600
58,300
81,900
95,800
115,500
132,100
162,300
165,600
149,600
133,900
128,000
101,400
155,200
153,000
448,800
401,660
400,151
337,616
491,051
795,114
768,608
776,630
965,470
966,624
1,256,640
1,522,245
1,352,421
1,414,891
1,202,068
1,156,123
1,221,039
1,263,745
1,341,681
1,587,841
2,253,802
3,092,678
4,108,661
3,886,414
3,557,937
3,557,9373,886,4144,108,6613,092,6782,253,8021,587,8411,341,6811,263,7451,221,0391,156,1231,202,0681,414,8911,352,4211,522,2451,256,640966,624965,470776,630768,608795,114491,051337,616400,151401,660448,800153,000155,200101,400128,000133,900149,600165,600162,300132,100115,50095,80081,90058,30041,600
   > Total Current Liabilities 
23,900
32,700
45,400
53,400
74,300
84,600
92,100
98,400
87,400
89,900
89,800
79,100
100,800
97,200
202,500
189,308
199,106
222,009
234,326
315,375
319,243
319,533
414,168
418,034
419,972
666,627
459,115
461,240
487,472
446,761
441,351
471,322
502,696
449,307
905,495
631,536
680,938
568,708
522,799
522,799568,708680,938631,536905,495449,307502,696471,322441,351446,761487,472461,240459,115666,627419,972418,034414,168319,533319,243315,375234,326222,009199,106189,308202,50097,200100,80079,10089,80089,90087,40098,40092,10084,60074,30053,40045,40032,70023,900
       Short-term Debt 
8,600
10,600
18,700
16,400
25,500
28,200
31,700
36,400
30,800
21,600
14,300
5,600
10,800
9,400
22,000
18,146
9,931
7,486
10,423
9,457
3,341
3,042
15,627
9,578
5,132
233,181
814
1,750
1,786
265
298
334
420
493
426,172
1,798
489
465
41,365
41,3654654891,798426,1724934203342982651,7861,750814233,1815,1329,57815,6273,0423,3419,45710,4237,4869,93118,14622,0009,40010,8005,60014,30021,60030,80036,40031,70028,20025,50016,40018,70010,6008,600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
435,975
434,181
334
420
493
426,172
1,798
489
465
486
4864654891,798426,172493420334434,181435,97500000000000000000000000000000
       Accounts payable 
0
0
0
0
16,600
18,600
17,500
18,900
14,700
21,100
19,900
21,300
32,400
26,700
64,700
62,965
64,903
75,233
53,995
71,194
72,950
83,411
96,470
117,982
92,988
113,440
129,124
130,972
148,510
128,608
280,248
296,473
306,814
264,471
287,098
362,326
418,927
329,831
142,825
142,825329,831418,927362,326287,098264,471306,814296,473280,248128,608148,510130,972129,124113,44092,988117,98296,47083,41172,95071,19453,99575,23364,90362,96564,70026,70032,40021,30019,90021,10014,70018,90017,50018,60016,6000000
       Other Current Liabilities 
15,300
22,100
26,700
37,000
32,200
37,800
42,900
43,100
41,900
47,200
55,600
52,200
57,600
61,100
115,800
108,197
65,838
67,077
98,258
66,346
161,876
97,898
129,140
137,323
152,828
137,690
304,855
302,230
310,786
291,172
131,122
143,512
167,229
157,407
158,490
224,944
210,670
186,201
-35,420,391
-35,420,391186,201210,670224,944158,490157,407167,229143,512131,122291,172310,786302,230304,855137,690152,828137,323129,14097,898161,87666,34698,25867,07765,838108,197115,80061,10057,60052,20055,60047,20041,90043,10042,90037,80032,20037,00026,70022,10015,300
   > Long-term Liabilities 
17,700
25,600
36,500
42,400
41,200
47,500
70,200
67,200
62,200
44,000
38,200
22,300
54,400
55,800
246,300
212,352
201,045
115,607
256,725
479,739
449,365
457,097
551,302
548,590
836,668
855,618
893,306
953,651
714,596
709,362
779,688
792,423
838,985
1,138,534
1,348,307
2,461,142
3,427,723
3,317,706
3,035,138
3,035,1383,317,7063,427,7232,461,1421,348,3071,138,534838,985792,423779,688709,362714,596953,651893,306855,618836,668548,590551,302457,097449,365479,739256,725115,607201,045212,352246,30055,80054,40022,30038,20044,00062,20067,20070,20047,50041,20042,40036,50025,60017,700
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
732,414
435,615
435,710
435,707
434,186
434,581
438,937
13,579
12,258
10,514
1,197,716
0
01,197,71610,51412,25813,579438,937434,581434,186435,707435,710435,615732,414000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,477
0
0
0
0
0
0
0
0
0
0
0
0000000000015,477000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
273,652
343,981
365,836
405,485
701,005
1,158,710
2,273,756
3,417,209
1,966,393
0
01,966,3933,417,2092,273,7561,158,710701,005405,485365,836343,981273,65200000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,054
162,110
154,917
233,475
225,299
222,209
553,239
997,787
2,076,785
3,059,080
1,770,481
0
01,770,4813,059,0802,076,785997,787553,239222,209225,299233,475154,917162,110115,054000000000000000000000000000
> Total Stockholder Equity
29,900
43,300
50,100
59,500
68,900
81,100
90,800
107,100
110,300
129,800
157,100
183,500
196,700
214,300
220,100
244,618
283,877
383,087
495,807
596,888
657,974
819,538
971,690
1,040,731
1,259,726
1,536,696
1,743,937
2,016,190
2,186,722
2,185,155
2,490,503
2,586,759
2,930,340
4,015,724
5,755,057
9,879,940
13,667,134
9,615,252
8,741,133
8,741,1339,615,25213,667,1349,879,9405,755,0574,015,7242,930,3402,586,7592,490,5032,185,1552,186,7222,016,1901,743,9371,536,6961,259,7261,040,731971,690819,538657,974596,888495,807383,087283,877244,618220,100214,300196,700183,500157,100129,800110,300107,10090,80081,10068,90059,50050,10043,30029,900
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,500
12,478
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3333333333333333333333212,47812,50000000000000000
   Retained Earnings 
16,000
21,800
28,500
37,700
46,700
57,300
64,200
81,300
84,100
99,700
124,900
151,000
167,200
189,800
201,000
231,821
276,554
344,841
421,012
489,254
570,807
674,070
762,067
851,577
996,197
1,181,687
1,359,910
1,523,688
1,606,117
1,694,962
1,808,055
1,836,180
1,830,439
3,722,073
5,470,779
9,268,012
13,507,241
9,898,203
9,260,629
9,260,6299,898,20313,507,2419,268,0125,470,7793,722,0731,830,4391,836,1801,808,0551,694,9621,606,1171,523,6881,359,9101,181,687996,197851,577762,067674,070570,807489,254421,012344,841276,554231,821201,000189,800167,200151,000124,90099,70084,10081,30064,20057,30046,70037,70028,50021,80016,000
   Accumulated Other Comprehensive Income 
-5,200
-9,200
-13,700
-19,600
-24,900
-35,200
-44,300
-52,400
-62,200
-74,800
-86,400
-96,100
-100,000
-116,000
-4,700
-13,386
-22,987
2,102
32,628
58,003
27,052
67,235
110,991
64,750
133,082
198,020
198,690
274,901
340,717
218,945
382,138
417,766
738,794
-46,958
-87,348
282,456
-175,553
-466,822
-336,038
-336,038-466,822-175,553282,456-87,348-46,958738,794417,766382,138218,945340,717274,901198,690198,020133,08264,750110,99167,23527,05258,00332,6282,102-22,987-13,386-4,700-116,000-100,000-96,100-86,400-74,800-62,200-52,400-44,300-35,200-24,900-19,600-13,700-9,200-5,200
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
212,244
239,986
271,346
300,408
332,911
361,231
394,342
410,020
429,376
441,733
447,454
0
0447,454441,733429,376410,020394,342361,231332,911300,408271,346239,986212,244000000000000000000000000000
   Treasury Stock0-263,586-106,290-99,907-38,397-49,129-217-101-101-101-101-101000000000000000000000000000
   Other Stockholders Equity 
19,100
30,700
35,300
41,400
47,100
59,000
70,900
78,200
88,400
104,900
118,600
128,600
129,500
140,500
11,300
13,705
30,308
36,141
42,164
49,628
60,112
78,230
98,629
124,401
130,444
156,986
185,334
212,143
239,885
271,245
300,307
332,810
361,014
340,606
371,623
329,469
335,443
183,868
-183,461
-183,461183,868335,443329,469371,623340,606361,014332,810300,307271,245239,885212,143185,334156,986130,444124,40198,62978,23060,11249,62842,16436,14130,30813,70511,300140,500129,500128,600118,600104,90088,40078,20070,90059,00047,10041,40035,30030,70019,100



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,671,262
Cost of Revenue-1,239,916
Gross Profit1,431,3461,431,346
 
Operating Income (+$)
Gross Profit1,431,346
Operating Expense-1,047,550
Operating Income383,796383,796
 
Operating Expense (+$)
Research Development226,927
Selling General Administrative846,803
Selling And Marketing Expenses0
Operating Expense1,047,5501,073,730
 
Net Interest Income (+$)
Interest Income96,400
Interest Expense-49,439
Other Finance Cost-678
Net Interest Income47,639
 
Pretax Income (+$)
Operating Income383,796
Net Interest Income47,639
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-850,1041,617,696
EBIT - interestExpense = 334,357
-850,104
-587,885
Interest Expense49,439
Earnings Before Interest and Taxes (EBIT)383,796-800,665
Earnings Before Interest and Taxes (EBITDA)576,196
 
After tax Income (+$)
Income Before Tax-850,104
Tax Provision--27,916
Net Income From Continuing Ops-159,298-822,188
Net Income-637,324
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,287,466
Total Other Income/Expenses Net-1,233,900-47,639
 

Technical Analysis of Bio-rad
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bio-rad. The general trend of Bio-rad is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bio-rad's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bio-Rad Laboratories Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 300.10 < 300.10 < 300.10.

The bearish price targets are: 271.00 > 271.00.

Tweet this
Bio-Rad Laboratories Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bio-Rad Laboratories Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bio-Rad Laboratories Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bio-Rad Laboratories Inc. The current macd is -4.02643416.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bio-rad price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bio-rad. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bio-rad price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bio-Rad Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) ChartBio-Rad Laboratories Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bio-Rad Laboratories Inc. The current adx is 30.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bio-rad shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Bio-Rad Laboratories Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bio-Rad Laboratories Inc. The current sar is 346.67.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bio-Rad Laboratories Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bio-Rad Laboratories Inc. The current rsi is 26.84. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Bio-Rad Laboratories Inc Daily Relative Strength Index (RSI) ChartBio-Rad Laboratories Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bio-Rad Laboratories Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bio-rad price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bio-Rad Laboratories Inc Daily Stochastic Oscillator ChartBio-Rad Laboratories Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bio-Rad Laboratories Inc. The current cci is -266.53128769.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bio-Rad Laboratories Inc Daily Commodity Channel Index (CCI) ChartBio-Rad Laboratories Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bio-Rad Laboratories Inc. The current cmo is -57.05641784.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bio-Rad Laboratories Inc Daily Chande Momentum Oscillator (CMO) ChartBio-Rad Laboratories Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bio-Rad Laboratories Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bio-Rad Laboratories Inc Daily Williams %R ChartBio-Rad Laboratories Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bio-Rad Laboratories Inc. The current atr is 7.88928583.

Bio-Rad Laboratories Inc Daily Average True Range (ATR) ChartBio-Rad Laboratories Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bio-Rad Laboratories Inc. The current obv is -9,634.

Bio-Rad Laboratories Inc Daily On-Balance Volume (OBV) ChartBio-Rad Laboratories Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bio-Rad Laboratories Inc. The current mfi is 22.33.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bio-Rad Laboratories Inc Daily Money Flow Index (MFI) ChartBio-Rad Laboratories Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bio-Rad Laboratories Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-10-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-10-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Bio-Rad Laboratories Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bio-Rad Laboratories Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.841
Ma 20Greater thanMa 50327.689
Ma 50Greater thanMa 100320.047
Ma 100Greater thanMa 200316.467
OpenGreater thanClose279.910
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bio-rad with someone you think should read this too:
  • Are you bullish or bearish on Bio-rad? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bio-rad? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bio-Rad Laboratories Inc

I send you an email if I find something interesting about Bio-Rad Laboratories Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bio-Rad Laboratories Inc.

Receive notifications about Bio-Rad Laboratories Inc in your mailbox!